We are live on
!
Find out more
BlackRock Portfolio holdings
AUM
$5.7T
1-Year Est. Return
30.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Fund
S&P 500
This Quarter
Est. Return
-0.45%
1 Year Est. Return
+30.48%
3 Year Est. Return
+100.82%
5 Year Est. Return
+133.76%
10 Year Est. Return
+503.47%
AUM
$5.7T
AUM Growth
-$187B
(-3.2%)
Cap. Flow
+$28.4B
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
27.85%
Holding
5,767
New
267
Increased
2,757
Reduced
1,917
Closed
126
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.64B |
| 2 |
Palo Alto Networks
PANW
|
+$2.16B |
| 3 |
Broadcom
AVGO
|
+$1.99B |
| 4 |
ExxonMobil
XOM
|
+$1.68B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.57B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$3.59B |
| 2 |
NVIDIA
NVDA
|
+$3.35B |
| 3 |
Apple
AAPL
|
+$2.59B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.71B |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$1.54B |
Sector Composition
| 1 | Technology | 30.11% |
| 2 | Financials | 11.87% |
| 3 | Healthcare | 10.05% |
| 4 | Industrials | 9.6% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDV
2126
iShares Core High Dividend ETF
HDV
$13.9B
| $93.2M | ﹤0.01% |
3,433,330
+23,135
| +0.7% | +$616K |
|
2127
iRadimed
IRMD
$1.2B
| $93.2M | ﹤0.01% |
967,787
-34,212
| -3% | -$3.42M |
|
2128
Monte Rosa Therapeutics
GLUE
$1.98B
| $92.7M | ﹤0.01% |
5,637,684
+1,456,523
| +35% | +$27.9M |
|
2129
EyePoint Inc
EYPT
$1.16B
| $92.5M | ﹤0.01% |
7,177,337
+389,465
| +6% | +$5.82M |
|
2130
Metallus
MTUS
$820M
| $92.4M | ﹤0.01% |
5,657,566
-1,083,354
| -16% | -$19.9M |
|
2131
NetEase
NTES
$83.1B
| $92.4M | ﹤0.01% |
825,067
-36,668
| -4% | -$4.55M |
|
2132
Innodata
INOD
$2.13B
| $92.3M | ﹤0.01% |
2,391,220
-27,148
| -1% | -$1.35M |
|
2133
Alkami Technology
ALKT
$1.9B
| $92.2M | ﹤0.01% |
5,885,203
+207,977
| +4% | +$3.83M |
|
|
UHT
2134
Universal Health Realty Income Trust
UHT
$592M
| $91.5M | ﹤0.01% |
2,260,453
+32,422
| +1% | +$1.34M |
|
2135
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
| $91M | ﹤0.01% |
562,774
-96,452
| -15% | -$16.2M |
|
2136
Liberty Media Series A
FWONA
$22.9B
| $91M | ﹤0.01% |
1,165,279
+16,977
| +1% | +$1.36M |
|
|
AMWD
2137
DELISTED
American Woodmark
AMWD
| $90.6M | ﹤0.01% |
2,274,896
+4,746
| +0.2% | +$252K |
|
2138
Harmony Gold Mining
HMY
$9.47B
| $90.6M | ﹤0.01% |
5,894,335
-469,861
| -7% | -$9.29M |
|
2139
Corvus Pharmaceuticals
CRVS
$1.25B
| $90.1M | ﹤0.01% |
6,160,422
+1,104,061
| +22% | +$17.6M |
|
|
CIM
2140
Chimera Investment
CIM
$1.09B
| $90M | ﹤0.01% |
7,173,129
-184,395
| -3% | -$2.41M |
|
2141
Harrow
HROW
$1.6B
| $90M | ﹤0.01% |
2,552,759
-15,643
| -0.6% | -$688K |
|
2142
TriMas Corp
TRS
$1.45B
| $89.7M | ﹤0.01% |
2,497,043
+99,761
| +4% | +$3.58M |
|
2143
Lincoln Educational Services
LINC
$1.41B
| $88.8M | ﹤0.01% |
2,182,514
-24,789
| -1% | -$780K |
|
2144
Intercorp Financial Services
IFS
$6.67B
| $88.5M | ﹤0.01% |
1,762,160
+23,066
| +1% | +$1.1M |
|
2145
TriNet
TNET
$2.64B
| $88.5M | ﹤0.01% |
2,428,200
-125,882
| -5% | -$6.01M |
|
2146
Universal Insurance Holdings
UVE
$1.04B
| $88.3M | ﹤0.01% |
2,584,241
+3,503
| +0.1% | +$113K |
|
2147
iShares MSCI ACWI ETF
ACWI
$33.3B
| $88.2M | ﹤0.01% |
637,535
-287,182
| -31% | -$41.3M |
|
|
MFA
2148
MFA Financial
MFA
$960M
| $88M | ﹤0.01% |
9,188,281
-216,827
| -2% | -$2.14M |
|
2149
Liberty Latin America Class C
LILAK
$1.51B
| $87.9M | ﹤0.01% |
10,963,783
+372,213
| +4% | +$2.66M |
|
|
MBX
2150
MBX Biosciences
MBX
$2.89B
| $87.8M | ﹤0.01% |
2,941,406
+21,650
| +0.7% | +$736K |
|
Similar funds
VCM
VPM
